The intravenous antibiotic Emblaveo, a combination of aztreonam and avibactam approved in Europe last year, was developed in ...
Pfizer faces stagnant revenue and patent cliffs. Learn why I downgraded PFE stock to Strong Sell despite a 24.7% YoY growth ...
System1, the creative effectiveness platform, has revealed consumers’ favourite ads from the 2025 Super Bowl: Lay’s, the NFL, ...
StockStory.org on MSN2h
Royalty Pharma Earnings: What To Look For From RPRXHealthcare royalties company Royalty Pharma (NASDAQ:RPRX) will be reporting earnings tomorrow morning. Here’s what to look ...
Ten months after Pfizer scored approval in Europe for Emblaveo (aztreonam and avibactam) to treat complicated intra-abdominal infections (cIAIs), AbbVie has done the same in the U.S., ...
Eliquis, a blood thinner marketed in partnership with Bristol Myers Squibb, is Pfizer's largest revenue stream at the moment.
The 67th running of the Daytona 500, the Great American Race arrives Sunday at Daytona International Speedway.
Healthcare stocks have something to offer every investor. If you're looking for high growth, you can try an innovative ...
Hosted on MSN9h
LL COOL J and Wife Simone I. Smith Team Up with Pfizer to Encourage Early Cancer DetectionO n what seemed like a normal day in 2004, LL COOL J’s wife Simone I. Smith, then in her 30s, was working out with her ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback